 ROCKAWAY, N.J., Feb. 28, 2021 GLOBE NEWSWIRE -- electroCore, Inc. Nasdaq: ECOR, a commercial-stage bioelectronic medicine company, today announced that it has entered into an agreement with Medistar2 PTY Limited Medistar whereby Medistar will serve as the exclusive distributor of the gammaCore SapphireTM non-invasive vagus nerve stimulator nVNS in Australia, supplying therapy to patients suffering with primary headache disorders. The announcement follows the granting of regulatory approval from the Australian Therapeutic Goods Administration TGA for the promotion and sale of the gammaCore Sapphire family of products. 